Literature DB >> 3144705

Recombinational resolution in primate cells of two homologous human DNA segments with a gradient of sequence divergence.

M Gomez-Pedrozo1, W S Hu, C K Shen.   

Abstract

Human alpha-thalassemia-2 genotype -alpha 4.2 is the result of meiotic recombination between two 1.3 kb long, homologous DNA segments, X(alpha 2) and X(alpha 1), located in the adult alpha globin locus. The two segments can also undergo intramolecular recombination on extrachromosomal vectors transfected into mitotically dividing primate cells (COS 7). The existence of a gradient of sequence divergence between X(alpha 2) and X(alpha 1) makes them an interesting system to study the relationship between efficiencies of homologous DNA recombination and the extent of dispersed and localized base mismatches. By partial restriction mapping and DNA sequencing of plasmids recombined in COS 7 cells and rescued from bacteria HB 101, we have determined the distribution of recombinational resolution sites along the two X blocks. Most, if not all, of the homologous recombination events between the two X blocks appear to be single crossing-over without efficient gene correction or repair of base mismatches. The distribution of the sites of recombinational resolution is inversely correlated with that of the gradient of sequence divergence, with only approximately 7% of the X recombinants resolved within the 3' third of the X blocks where two diverged Alu family repeats reside. The Alu sequence within which one of the X recombinants resolved is homologous to a previously characterized alpha thalassemia deletion point.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144705      PMCID: PMC339007          DOI: 10.1093/nar/16.23.11237

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  A sex chromosome rearrangement in a human XX male caused by Alu-Alu recombination.

Authors:  F Rouyer; M C Simmler; D C Page; J Weissenbach
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

2.  Differential effects of base-pair mismatch on intrachromosomal versus extrachromosomal recombination in mouse cells.

Authors:  A S Waldman; R M Liskay
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Recombination at the human alpha-globin gene cluster: sequence features and topological constraints.

Authors:  R D Nicholls; N Fischel-Ghodsian; D R Higgs
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

4.  Repair of single-stranded loops in heteroduplex DNA transfected into mammalian cells.

Authors:  U Weiss; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Genetic recombination and disease.

Authors:  M Siniscalco
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

6.  Extrachromosomal and chromosomal gene conversion in mammalian cells.

Authors:  J Rubnitz; S Subramani
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 7.  Enzymes of general recombination.

Authors:  M M Cox; I R Lehman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

8.  Intramolecular recombination between partially homologous sequences in Escherichia coli and Xenopus laevis oocytes.

Authors:  J P Abastado; S Darche; F Godeau; B Cami; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Reconstruction of human alpha thalassemia-2 genotypes in monkey cells.

Authors:  W S Hu; C K Shen
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

10.  Sequence homology requirements for intermolecular recombination in mammalian cells.

Authors:  D Ayares; L Chekuri; K Y Song; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

View more
  1 in total

1.  Homology requirements for unequal crossing over in humans.

Authors:  A B Metzenberg; G Wurzer; T H Huisman; O Smithies
Journal:  Genetics       Date:  1991-05       Impact factor: 4.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.